Integral Diagnostics Limited

Informe acción ASX:IDX

Capitalización de mercado: AU$573.1m

Integral Diagnostics Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Ian Kadish

Chief Executive Officer (CEO)

AU$1.1m

Compensación total

Porcentaje del salario del CEO71.2%
Permanencia del CEO7yrs
Participación del CEO0.2%
Permanencia media de la dirección3.7yrs
Promedio de permanencia en la Junta Directiva1.8yrs

Actualizaciones recientes de la dirección

Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Nov 22
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Recent updates

Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Feb 21
Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Nov 22
Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

Feb 20
Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Dec 14
These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

May 26
Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Feb 28
Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

Feb 25
Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Oct 29
Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

Sep 13
Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued

Jun 04
An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued

Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?

May 14
Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?

Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?

May 03
Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?

We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt

Apr 16
We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt

Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Mar 27
Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?

Mar 17
Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?

The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About

Mar 07
The Trends At Integral Diagnostics (ASX:IDX) That You Should Know About

Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend

Feb 25
Here's What We Like About Integral Diagnostics' (ASX:IDX) Upcoming Dividend

Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?

Feb 23
Is Integral Diagnostics Limited (ASX:IDX) Popular Amongst Institutions?

Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?

Feb 13
Have Insiders Been Selling Integral Diagnostics Limited (ASX:IDX) Shares?

Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Feb 03
Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)

Jan 24
Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)

Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?

Jan 14
Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?

Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return

Jan 05
Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return

Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Dec 26
Is Integral Diagnostics (ASX:IDX) A Risky Investment?

At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?

Dec 17
At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?

What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend

Dec 08
What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend

Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture

Nov 29
Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture

Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?

Nov 19
Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?

Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Sep 20
Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Sep 11
Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Could Integral Diagnostics Limited (ASX:IDX) Have The Makings Of Another Dividend Aristocrat?

Sep 03
Could Integral Diagnostics Limited (ASX:IDX) Have The Makings Of Another Dividend Aristocrat?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Ian Kadish en comparación con los beneficios de Integral Diagnostics?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023n/an/a

-AU$58m

Sep 30 2023n/an/a

-AU$16m

Jun 30 2023AU$1mAU$782k

AU$25m

Mar 31 2023n/an/a

AU$23m

Dec 31 2022n/an/a

AU$21m

Sep 30 2022n/an/a

AU$18m

Jun 30 2022n/aAU$781k

AU$15m

Mar 31 2022n/an/a

AU$18m

Dec 31 2021n/an/a

AU$22m

Sep 30 2021n/an/a

AU$26m

Jun 30 2021AU$2mAU$736k

AU$31m

Mar 31 2021n/an/a

AU$32m

Dec 31 2020n/an/a

AU$32m

Sep 30 2020n/an/a

AU$28m

Jun 30 2020AU$1mAU$635k

AU$23m

Mar 31 2020n/an/a

AU$22m

Dec 31 2019n/an/a

AU$21m

Sep 30 2019n/an/a

AU$21m

Jun 30 2019AU$876kAU$549k

AU$21m

Mar 31 2019n/an/a

AU$19m

Dec 31 2018n/an/a

AU$17m

Sep 30 2018n/an/a

AU$16m

Jun 30 2018AU$711kAU$489k

AU$15m

Mar 31 2018n/an/a

AU$15m

Dec 31 2017n/an/a

AU$15m

Sep 30 2017n/an/a

AU$15m

Jun 30 2017AU$50kAU$44k

AU$15m

Compensación vs. Mercado: La compensación total ($USD714.24K) de Ian está en línea con el promedio de empresas de tamaño similar en el mercado Australian ($USD775.51K).

Compensación vs. Ingresos: La compensación de Ian ha aumentado mientras la empresa no es rentable.


CEO

Ian Kadish (60 yo)

7yrs

Permanencia

AU$1,097,723

Compensación

Dr. Ian Kadish, MBBCh, MBA, has been the Chief Executive Officer, Managing Director and Director at Integral Diagnostics Limited since May 22, 2017. Dr. Kadish serves as Independent Non-Executive Director...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Ian Kadish
CEO, MD & Director7yrsAU$1.10m0.24%
A$ 1.4m
Jacqueline Milne
Executive Director4.5yrsAU$1.05m0.011%
A$ 61.7k
Scott Paterson
Chief Financial Officerless than a yearsin datossin datos
Julian Gully
Chief Information Officer4.7yrssin datossin datos
Nikki Valle
General Counsel & Company Secretaryless than a yearsin datossin datos
Lisa Sorger
Chief Medical Officer2.8yrssin datossin datos

3.7yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de IDX se considera experimentado (3.6 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Ian Kadish
CEO, MD & Directorno dataAU$1.10m0.24%
A$ 1.4m
Jacqueline Milne
Executive Director4.5yrsAU$1.05m0.011%
A$ 61.7k
Raelene Murphy
Independent Non-Executive Director6.6yrsAU$137.50k0.013%
A$ 75.8k
Andrew Fay
Independent Non-Executive Director1.8yrsAU$131.77k0.036%
A$ 208.3k
Ingrid Player
Independent Non-Executive Directorless than a yearsin datos0.015%
A$ 85.7k
James Hall
Independent Non-Executive Directorless than a yearsin datos0.065%
A$ 371.7k

1.8yrs

Permanencia media

58yo

Promedio de edad

Junta con experiencia: La junta directiva de IDX no se considera experimentada (1.8 años de permanencia promedio), lo que sugiere una nueva junta directiva.